|
000
| 01062cas 2200265za 4500 |
|---|
| 001 | 9.854141 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107155008 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 180322d20152016oncar p o |||f0 a0eng|d |
|---|
| 022 | |a2561-6099 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH161-9E-PDF |
|---|
| 222 | 0|aHealth Canada new drug authorizations, ... highlights |
|---|
| 245 | 00|aHealth Canada new drug authorizations, ... highlights |h[electronic resource]. |
|---|
| 246 | 33|aNew active substances, biosimilars, and generic pharmaceuticals |
|---|
| 260 | |a[Ottawa] : |bHealth Canada, |c[2016-2017] |
|---|
| 310 | |aAnnual |
|---|
| 362 | 1 |aBegan with 2015; ceased with 2016. |
|---|
| 500 | |aIssued also in French under title: Autorisations de nouveau médicaments par Santé Canada, faits saillants de ... |
|---|
| 692 | 07|2gccst|aNonprescription drugs |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tAutorisations de nouveau médicaments par Santé Canada, faits saillants de ...|w(CaOODSP)9.854145 |
|---|